导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -26.77% | 1034/1050 |
| 近一周 | -3.70% | 924/1104 |
| 近一月 | -3.32% | 392/1102 |
| 近一季 | -9.64% | 643/1092 |
| 近半年 | -20.46% | 997/1070 |
| 近一年 | -15.81% | 829/1018 |
| 近两年 | 10.25% | 838/926 |
| 近三年 | -10.20% | 734/834 |
| 成立以来 | 168.41% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-14.56% 1049/1070 |
-11.29% 943/1101 |
- - |
- - |
| 2025 | 21.41% 641/1065 |
-5.53% 993/1014 |
7.95% 158/1038 |
5.02% 934/1050 |
13.36% 26/1065 |
| 2024 | 14.89% 177/1011 |
6.27% 79/960 |
-5.46% 656/983 |
15.10% 225/991 |
-0.64% 356/1011 |
| 2023 | -25.09% 776/952 |
-2.43% 730/880 |
-10.26% 779/895 |
-6.20% 376/915 |
-8.79% 800/952 |
| 2022 | 7.75% 7/867 |
-12.06% 149/773 |
11.25% 217/806 |
-0.55% 19/845 |
10.75% 67/867 |
| 2021 | 10.61% 237/740 |
-11.55% 518/580 |
39.41% 12/659 |
-5.28% 366/704 |
-5.29% 597/740 |
| 2020 | 75.38% 114/554 |
1.83% 116/419 |
30.36% 126/466 |
5.97% 345/517 |
24.68% 69/554 |
| 2019 | - - |
- - |
2.20% 155/1228 |
9.97% 110/390 |
7.68% 252/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 金信消费升级股票A VS. 东吴新产业精选股票A(580008) |